GlassScriptPhysician profile
Kaitlin Collins
NPI 1750144473
$1,129.25
in general payments reported to CMS, 2019-2025
16 companies · $589 in 2025
The $589 reported for 2025 was more than what 76% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $540 · 2025: $589.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,002 · Education: $127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,002.27 |
| Education | $126.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $182.26 | 2024 | |
| Sobi, INC | $152.24 | 2025 | |
| Csl Behring | $123.01 | 2024-2025 | Hemgenix, Idelvion |
| Adaptive Biotechnologies Corporation | $120.80 | 2024-2025 | Clonoseq |
| Pfizer INC. | $92.17 | 2024-2025 | |
| Alexion Pharmaceuticals, INC. | $85.63 | 2024-2025 | Ultomiris |
| Servier Pharmaceuticals LLC | $81.59 | 2024-2025 | |
| Novo Nordisk INC | $70.39 | 2024-2025 | Alhemo, Novoeight, Rebinyn |
| Agios Pharmaceuticals, INC. | $42.98 | 2024-2025 | Pyrukynd |
| Bayer Healthcare Pharmaceuticals INC. | $37.16 | 2025 | |
| Qol Medical, LLC | $32.51 | 2025 | Sucraid |
| Biomarin Pharmaceutical INC. | $24.62 | 2024 | Roctavian |
| Takeda Pharmaceuticals U.S.A., INC. | $24.10 | 2024 | Vonvendi |
| Rare Disease Therapeutics, INC. | $23.35 | 2025 | Xromi |
| Incyte Corporation | $19.75 | 2025 | Niktimvo |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tempus Ai, INC | $16.69 | 2025 | Xt Cdx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaitlin Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.